Details of the Drug
General Information of Drug (ID: DMJ4Z7W)
Drug Name |
Styrylboronic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
styrylboronic acid; 6783-05-7; (E)-Styrylboronic acid; trans-2-Phenylvinylboronic acid; E-Phenylethenylboronic acid; 2-Phenylvinylboronic Acid; [(E)-2-phenylethenyl]boronic acid; 4363-35-3; trans-Phenylvinylboronic acid; (E)-Phenylethenylboronic acid; CHEMBL559289; Trans-Beta-Styreneboronic Acid; Boronic acid, [(1E)-2-phenylethenyl]-; [(E)-styryl]boronic acid; 2-phenylethenylboronic Acid; ((E)-Styryl)boronic acid; [(E)-2-phenylvinyl]boronic acid; trans-styryl boronic acid; AC1NWBO3; (E)-phenylvinylboronic acid
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 |
Molecular Weight | 147.97 | |||||||||||||||||||||
Logarithm of the Partition Coefficient | Not Available | ||||||||||||||||||||||
Rotatable Bond Count | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||